OS Therapies
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -124 | -112 | ||
EBITDA | -6,754 | -4,424 | -3,876 | |
EBIT | -6,879 | -4,536 | -3,876 | |
Net Income | -13,460 | -6,879 | -4,536 | -3,876 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,730 | -4,706 | -2,676 | -3,591 |
Cash | 269 | 1,876 | 2,802 | 2,971 |
Basic Shares | 35,214 | 31,956 | 25,114 | 21,249 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2 | -4 | ||
EBITDA | -6,828 | -4,338 | -4,445 | |
EBIT | -6,831 | -4,342 | -4,446 | |
Net Income | -28,753 | -8,882 | -7,791 | -6,254 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,704 | -7,282 | -3,006 | -3,792 |
Cash | 269 | 5,533 | 38 | 171 |
Basic Shares | 35,214 | 20,869 | 20,049 | 23,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.42 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.18 |
